Methyl 2-Bromohexanoate (CAS NO : 5445-19-2)

Methyl 2-bromohexanoate (CAS No: 5445-19-2) serves as a sophisticated alpha-halogenated ester intermediate, increasingly vital for the precision synthesis of heterocyclic frameworks such as 2-butyl-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one within the U.S. pharmaceutical sector. The compound’s high reactivity, driven by the dual functionality of its bromine and ester groups, facilitates essential substitution, alkylation, and condensation reactions required for producing high-purity antihypertensive agents, anticonvulsants, and specialty agrochemical building blocks like pyrethroids and triazoles. As the American chemical market shifts toward high-performance specialty intermediates, Methyl 2-bromohexanoate is seeing robust demand within the CDMO sector, particularly for advanced route scouting and the development of complex bioactive molecules that require stringent 98% purity levels to satisfy regulatory standards. As an established Methyl 2-Bromohexanoate supplier offering 98% purity, we provide a dependable supply chain, consistent quality, and complete regulatory documentation, including a CoA and TDS across all grades. Beyond supply, we support partners through the entire product lifecycle—from route scouting, process development, and analytical method development to scale-up, optimization, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory filings, and global logistics coordination.